Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Evans, Ronald M  [Clear All Filters]
2014
Lister R, Pelizzola M, Kida YS, R Hawkins D, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, et al. Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2014;514(7520):126.
2016
Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, Berggren T, Evans RM, Gage FH, Hunter T. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife. 2016;5.
2019
Fu T, Coulter S, Yoshihara E, Oh TGyu, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, et al. FXR Regulates Intestinal Cancer Stem Cell Proliferation. Cell. 2019;176(5):1098-1112.e18.
Ward JM, Stoyas CA, Switonski PM, Ichou F, Fan W, Collins B, Wall CE, Adanyeguh I, Niu C, Sopher BL, et al. Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease. Cell Rep. 2019;26(5):1189-1202.e6.
2022
Shi Y, Evans RM, Gage FH. Oleic acid regulates hippocampal neurogenesis as a TLX ligand. Proc Natl Acad Sci U S A. 2022;119(15):e2203038119.
2023
Yoon BKyung, Kim H, Oh TGyu, Oh SKyu, Jo S, Kim MK, Chun K-H, Hwang N, Lee S, Jin S, et al. PHGDH preserves one-carbon cycle to confer metabolic plasticity in chemoresistant gastric cancer during nutrient stress. Proc Natl Acad Sci U S A. 2023;120(21):e2217826120.
Abe Y, Kofman ER, Almeida M, Ouyang Z, Ponte F, Mueller JR, Cruz-Becerra G, Sakai M, Prohaska TA, Spann NJ, et al. RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression. Mol Cell. 2023.
Antal CE, Oh TGyu, Aigner S, Luo E-C, Yee BA, Campos T, Tiriac H, Rothamel KL, Cheng Z, Jiao H, et al. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Nat Commun. 2023;14(1):5195.
2024
Hong S-H, Castro G, Wang D, Nofsinger R, Kane M, Folias A, Atkins AR, Yu RT, Napoli JL, Sassone-Corsi P, et al. Targeting nuclear receptor corepressors for reversible male contraception. Proc Natl Acad Sci U S A. 2024;121(9):e2320129121.